Mejía Miguel Eduardo, Lacau-Mengido Isabel María
Laboratorio de Regulación Hipofisaria, Instituto de Biología y Medicina Experimental-CONICET, Vuelta de Obligado 2490, 1428 Buenos Aires, Argentina.
Theriogenology. 2005 Mar 15;63(5):1266-76. doi: 10.1016/j.theriogenology.2004.05.023.
In Argentina, most dairy cows with endometritis are treated with prostaglandin (PGF(2alpha) or its analogs) and insemination is withheld until there are no signs of endometritis. The objective of the present study was to evaluate if this method of managing endometritis enhances reproductive performance. Three experiments were conducted over 4 years in a large farm in the west of Buenos Aires province. In Experiment 1, half of the cows diagnosed with endometritis (>1.5-fold difference in diameter of uterine horns, as determined by rectal palpation) received standard endometritis management (treatment with tiaprost, a PGF(2alpha) analog, rectal palpation every 20 days, and withholding of AI until endometritis apparently resolved) and the other half was untreated, with AI at the first estrus after the voluntary waiting period. Untreated cows were inseminated and conceived 20 days earlier than treated cows, and the pregnancy rate by Day 90 postpartum was higher in the untreated group. In Experiment 2, cows with endometritis were divided into four groups according to the severity of symptoms; within each group, cows were allocated to treatment or control, as in Experiment 1. Although first service conception rate decreased as endometritis severity increased, reproductive performance in treated versus control cows was similar to that of Experiment 1 (with no interaction due to degree of endometritis). Re-evaluation of the treated cow (to confirm uterine "normality") may have been responsible for the delay in conception in both experiments. The objective of Experiment 3 was to determine the effects of tiaprost treatment on clinically normal postpartum cows (no evidence of endometritis). Tiaprost treatment reduced the interval from calving to conception in multiparous cows, but it delayed conception and reduced the conception rate in primiparous cows. In conclusion, treatment with tiaprost impaired reproductive performance in primiparous cows (in the absence of endometritis). Furthermore, the standard treatment for endometritis (treatment with a prostaglandin analog and withholding insemination until clinical signs abated) impaired reproductive performance and increased costs.
在阿根廷,大多数患有子宫内膜炎的奶牛会接受前列腺素(PGF₂α 或其类似物)治疗,并且在子宫内膜炎症状消失之前不进行授精。本研究的目的是评估这种子宫内膜炎管理方法是否能提高繁殖性能。在布宜诺斯艾利斯省西部的一个大型农场进行了为期4年的三项实验。在实验1中,一半被诊断为子宫内膜炎的奶牛(通过直肠触诊确定子宫角直径差异超过1.5倍)接受标准的子宫内膜炎管理(用替前列素治疗,替前列素是一种PGF₂α 类似物,每20天进行直肠触诊,在子宫内膜炎明显消退之前不进行人工授精),另一半不进行治疗,在自愿等待期后的第一次发情期进行人工授精。未治疗的奶牛比治疗的奶牛早20天进行授精并受孕,产后90天时未治疗组的妊娠率更高。在实验2中,根据症状严重程度将患有子宫内膜炎的奶牛分为四组;在每组中,奶牛被分配到治疗组或对照组,如同实验1。尽管首次输精受孕率随着子宫内膜炎严重程度的增加而降低,但治疗组与对照组奶牛的繁殖性能与实验1相似(不存在因子宫内膜炎程度导致的相互作用)。对治疗奶牛进行重新评估(以确认子宫“正常”)可能是两个实验中受孕延迟的原因。实验3的目的是确定替前列素治疗对产后临床正常奶牛(无子宫内膜炎证据)的影响。替前列素治疗缩短了经产奶牛从产犊到受孕的间隔,但延迟了初产奶牛的受孕并降低了其受孕率。总之,替前列素治疗损害了初产奶牛(在无子宫内膜炎的情况下)的繁殖性能。此外,子宫内膜炎的标准治疗方法(用前列腺素类似物治疗并在临床症状消退之前不进行授精)损害了繁殖性能并增加了成本。